Vimarsana
Biggest News Aggregation in the World

Page 6 - Eric Schadt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Schadt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Schadt Today - Breaking & Trending Today

Sema4 to lay off about 250 people, close Branford laboratory - Vimarsana News

Sema4 to lay off about 250 people, close Branford laboratory

The genomic-testing specialist Sema4 is making big changes that include the elimination of about 250 jobs and the closing of its laboratory in Branford.

Why Sema4 Holdings Stock Is Crashing Today - Vimarsana News

Why Sema4 Holdings Stock Is Crashing Today

The healthcare company delivered plenty of bad news in its Q2 update.

Source: fool.com
Related Topics:
Matthew DavisEric Schadt
Sema4 to lay off 13% of workforce, close Branford laboratory; founder Eric Schadt resigns - Vimarsana News

Sema4 to lay off 13% of workforce, close Branford laboratory; founder Eric Schadt resigns

Sema4 Holdings Corp., a publicly traded health information company based in Stamford, said it plans to eliminate about 250 positions, roughly 13% of its workforce. The restructuring was announced Monday as part of Sema4’s second quarter financial results. The company has eliminated about 30% of its positions, including layoffs that occurred during the first half of the year. Sema4 plans to move its hereditary cancer testing operations from Stamford to Gaithersburg, Maryland at the end of the third quarter, according to the announcement.

Sema4 lays off 250 employees, founder steps down - Vimarsana News

Sema4 lays off 250 employees, founder steps down

The layoffs represent 13% of the AI-backed genomic and clinical data company's workforce.

Sema4 (NASDAQ:SMFR) Earns Buy Rating from Analysts at The Goldman Sachs Group - Vimarsana News

Sema4 (NASDAQ:SMFR) Earns Buy Rating from Analysts at The Goldman Sachs Group

Investment analysts at The Goldman Sachs Group began coverage on shares of Sema4 (NASDAQ:SMFR – Get Rating) in a research report issued on Thursday, The Fly reports. The firm set a “buy” rating on the stock. A number of other equities analysts have also recently issued reports on SMFR. Compass Point decreased their price objective […]